IP Library Granted Patent US 7,833,220
Granted Patent B2
US 7,833,220 · App. 10/504,302 · Granted Nov 16, 2010

Method and apparatus treating tissue adjacent a bodily conduit with thermocompression and drugs

Assignee: Boston Scientific Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,220
App. No.
10/504,302
Granted
Nov 16, 2010
Kind
B2
Abstract

A method and apparatus ( 100 ) of treating tissue adjacent a bodily conduit using thermotherapy, while preventing obstructions of the bodily conduit due to edema, includes injection of a drug-encapsulated within a heat-sensitive carrier, such as a liposome, within a region of tissue to be treated. The heat produced by the energy-emitting source ( 110 ) heats a portion of the tissue surrounding the bodily conduit to a temperature of approximately 43° C. for a time sufficient to destroy the heated portion of the tissue. In addition, the heat produced by the energy-emitting source ( 110 ) activates the heat-sensitive carrier to activate the release of the encapsulated drug and the drug targets the tissue to be heated. The focused energy of the energy-emitting source together with the compression acting on the target area can assist in delivering drugs to the target area so that a natural stent has a long term efficacy.

Claims (31)

1. A method of thermotherapy for treating tissue adjacent a bodily conduit comprising the steps of:

inserting a catheter containing an energy-emitting source into a bodily conduit so that the energy-emitting source is positioned adjacent a region of tissue to be treated so that focused energy from the energy-emitting source heats the tissue to be treated adjacent the bodily conduit, the catheter defining a central lumen and the energy-emitting source disposed within the central lumen;

inflating a compression balloon disposed on the catheter with a circulating fluid at a temperature in the range of approximately 30° C. to approximately 60° C. to a pressure sufficient to expand the bodily conduit walls and to compress the tissue to be treated while the energy-emitting source is controlled to heat the tissue, the inflating including circulating the fluid into the compression balloon via a plurality of inlets disposed at a first location near a proximal end portion of the compression balloon and out of the compression balloon and into the central lumen of the catheter via a plurality of outlets disposed at second location near a distal portion of the compression balloon, the first location being disposed proximally of the second location, the plurality of outlets in fluid communication with the central lumen;

injecting a drug encapsulated within a heat-sensitive carrier within the region of the tissue to be treated; and

heating, via the energy-emitting source, a portion of the tissue to be treated to a temperature of approximately 43° C. for a time sufficient to destroy the heated portion of the tissue to be treated, the heat activating the heat-sensitive carrier to release the encapsulated drug such that the drug targets the tissue to be treated.

2. The method according to claim 1 , wherein the tissue to be treated is the prostate and the drug encapsulated within the heat-sensitive carrier treats prostatitis.

3. The method according to claim 1 , wherein the carrier is a heat-sensitive liposome.

4. The method according to claim 1 , wherein the step of injecting the drug encapsulated within a heat-sensitive carrier occurs within the bloodstream of a patient.

5. The method according to claim 4 , wherein the drug encapsulated within the heat-sensitive carrier is adjacent the target tissue when the heating step begins.

6. The method according to claim 1 , wherein the circulating fluid is configured to maintain the temperature of the bodily conduit walls above 30° C.

7. The method according to claim 1 , wherein the inflated compression balloon maintains pressure of about 10-25 psi during at least a portion of the thermotherapy.

8. The method according to claim 1 , wherein the circulating fluid is sufficiently warm to denature proteins of the bodily conduit walls, allowing the bodily conduit walls to conform to the expanded shape of the bodily conduit created by the compression balloon, such that the expanded bodily conduit walls do not return to their previous shape after the compression balloon is deflated and removed.

9. The method according to claim 1 , further comprising deflating and removing the compression balloon.

10. The method according to claim 1 , wherein the expanded bodily conduit walls remain expanded after the compression balloon is deflated and removed.

11. The method of claim 1 , wherein the energy-emitting source is a microwave antenna.

12. The method according to claim 1 , wherein the compression balloon surrounds the catheter and the electromagnetic energy-emitting source.

13. The method according to claim 1 , further comprising:

terminating the heating;

maintaining the pressure in the compression balloon after the terminating the heating for a time period sufficient to reinforce the expanded position of the bodily conduit walls; and

removing the electromagnetic energy-emitting containing catheter with compression balloon.

14. A method of thermotherapy for treating tissue adjacent a bodily conduit comprising the steps of:

inserting a catheter containing an energy-emitting source into a bodily conduit so that the energy-emitting source is positioned adjacent a region of tissue to be treated so that focused energy from the energy-emitting source heats the tissue to be treated adjacent the bodily conduit, the catheter defining a central lumen and the energy-emitting source disposed within the central lumen;

inflating a compression balloon disposed on the catheter to a pressure sufficient to expand the bodily conduit walls and to compress the tissue to be treated while the energy-emitting source is controlled to heat the tissue, the balloon having a length and a midpoint, the inflating including circulating fluid into the compression balloon via a plurality of inlets disposed at a first location proximal of the midpoint of the compression balloon and out of the compression balloon and into the central lumen of the catheter via a plurality of outlets disposed at a second location distal of the midpoint of the compression balloon, the plurality of outlets in fluid communication with the central lumen;

injecting a drug encapsulated within a heat-sensitive carrier within the region of the tissue to be treated;

heating a portion of the tissue surrounding the bodily conduit to a temperature of approximately 43° C. for a time sufficient to destroy the heated portion of the tissue via the electromagnetic energy-emitting source, the fluid being circulated during the heating step; and

terminating the heating of the tissue upon completion of the time sufficient to destroy the heated portion of the tissue.

15. The method according to claim 14 , wherein the circulating fluid is configured to maintain the temperature of the bodily conduit walls above 30° C.

16. The method according to claim 14 , wherein circulating fluid is at a temperature in the range of approximately 30° C. to approximately 60° C.

17. The method according to claim 14 , further comprising:

maintaining the pressure in the compression balloon after the termination of the heating for a time period sufficient to reinforce the expanded position of the bodily conduit walls; and

removing the electromagnetic energy-emitting containing catheter with compression balloon, the expanded bodily conduit walls remaining open after the removing.

Assignments (6)
SECURITY INTEREST Recorded May 21, 2021
From: MEDIFOCUS INC.
To: ASSET PROFITS LIMITED
Reel/Frame 056317/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2012
From: BOSTON SCIENTIFIC CORPORATION
To: MEDIFOCUS, INC.
Reel/Frame 029061/0412 →
RELEASE OF COLLATERAL ASSIGNMENT OF PATENTS AS SECURITY Recorded Apr 9, 2009
From: MANUFACTURERS AND TRADERS TRUST COMPANY
To: CELSION CORPORATION
Reel/Frame 022520/0831 →
SECURITY AGREEMENT Recorded Dec 27, 2007
From: CELSION CORPORATION
To: MANUFACTURERS AND TRADERS TRUST COMPANY
Reel/Frame 020288/0388 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2007
From: CELSION CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 020092/0758 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2005
From: MON, JOHN; FENN, ALAN J.
To: CELSION CORPORATION
Reel/Frame 016695/0086 →
Continuity (2)
Provisional Application 6035675000 · Feb 15, 2002
Related Publication 20050203498A1 · Sep 15, 2005